AMEN provides medical information for Arabic speakers in Israel and beyondAccess, MPE13 February 2024
EMA CHMP gives positive opinion on CAR-T treatment idecabtagene vicleucel (Abecma) in earlier lines of therapy for relapsed and refractory myelomaAccess, Myeloma30 January 2024
EMA CHMP confirms recommendation for non-renewal of Blenrep marketing authorisationAccess, MPE15 December 2023
The European Commission grants final approval for elranatamab for the treatment of relapsed or refractory myelomaAccess, Myeloma8 December 2023
MPE launches European Amyloidosis Diagnosis Pathway to promote early detection of the rare diseaseAccess, AL amyloidosis26 October 2023
EMA CHMP gives positive recommendation to elranatamab for the treatment of relapsed or refractory myelomaAccess, MPE, Myeloma13 October 2023
EMA CHMP recommends non-renewal of marketing authorisation for Blenrep®Access, Myeloma22 September 2023
EMA recommends expansion of melphalan flufenamide (Pepaxti®) marketing authorisationAccess, Myeloma18 September 2023
